Zenith Pharma
Zenith Pharma is a Moroccan pharmaceutical company that develops, in-licenses, and distributes 207 pharmaceutical products across 12 therapeutic categories to healthcare providers, hospitals, and pharmacies across Morocco.
- Company typePrivate
- Founded2002
- HeadquartersSidi Maarouf, Morocco
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Zenith Pharma firmographics
Firmographics- Name
- Zenith Pharma
- Legal name
- Zenith Pharma
- Website
- https://zenithpharma.ma
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Zenith Pharma is a Moroccan pharmaceutical company that develops, in-licenses, and distributes 207 pharmaceutical products across 12 therapeutic categories to healthcare providers, hospitals, and pharmacies across Morocco.
- Ownership category
- akta.pro rank
Zenith Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industry
- Full-Line Pharmaceutical Wholesalers (HLAIAJAA)
Keywords
Where Zenith Pharma is headquartered
LocationHeadquarters
- HQ city
- Sidi Maarouf
- HQ country
- Morocco
- HQ region
- Africa
Offices2 records
Markets served
Zenith Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical product sales: Zenith Pharma generates revenue through the development, manufacturing, and commercialization of pharmaceutical products across 12 therapeutic categories including cardiology, oncology, neurology, and pediatrics. The company sells both proprietary products and products through partnerships with international pharmaceutical firms.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Zenith Pharma product offering
Product offeringCore offering
Zenith Pharma develops, manufactures, and commercializes a portfolio of 207 pharmaceutical products across 12 therapeutic categories (musculoskeletal, cardiology, dermatology, gastroenterology, infectiology, oncology-hospital, ophthalmology, pediatrics, pharmacy/OTC, respiratory, central nervous system, and uro-gynecology). The company sells both proprietary in-house branded generics under the Zenith house brand and products through partnerships with leading international pharmaceutical firms, distributing these products to hospitals, clinics, and pharmacies across Morocco.
Product overview
Zenith Pharma is a Moroccan pharmaceutical company established in 2002, serving as a key player in the pharmaceutical industry in Morocco. The company operates as a pharmaceutical distributor and marketer with a broad portfolio of 207 products spanning 12 therapeutic categories: Locomotor (musculoskeletal), Cardiology, Dermatology, Gastroenterology, Infectiology, Oncology-Hospital, Ophthalmology, Pediatrics, Pharmacy (dietary supplements and OTC), Respiratory, Central Nervous System (CNS), and Uro-Gynecology. The portfolio includes both in-house branded products (many carrying the 'Zenith' house brand, such as Imantinib Zenith, Pemetrexed Zenith, Temozolomide Zenith, Ibandro Zenith, Docetaxel Zenith, Anastrozole Zenith, Bicalutamide Zenith, Létrozole Zenith, Donepezil Zenith, and Exemestane Zenith in oncology; Co-Arapro, Co-Zenovan, Co-Iprel in fixed-dose combinations for cardiology) as well as licensed and imported brands (such as Fraxiparine, Halaven, Irinotecan Zenith, Kamagra, Gynoflor, Sensodyne, Parodontax, Physiodose, Physiolac in pediatrics). The company's products range from prescription pharmaceuticals (oncology chemotherapy agents, antipsychotics, antidepressants, anticoagulants, antidiabetics, cardiovascular drugs) to OTC/dietary supplements (Carbozen, Magnezen, Suprabiotique, Multizen, Levure plus). The therapeutic areas are organized into categories on the website and individual product pages provide dosage forms, strengths, and indications.
Differentiator
Problem solved
Functional benefit
Products and services
- Arapro® 150mg Cardiology product, angiotensin II receptor blocker, 150mg dosage, for hypertension treatment.
- Bisocard® 10mg Cardiology product, beta-blocker, 10mg dosage, for cardiovascular conditions.
- Imantinib Zenith® 400mg Oncology hospital product, imatinib mesylate tyrosine kinase inhibitor, 400mg dosage, indicated for Philadelphia chromosome-positive chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal stromal tumors, and related conditions.
- Pemetrexed Zenith® 500mg Oncology hospital product, antimetabolite chemotherapy, 500mg presentation.
- Humorex® 10mg Central nervous system product, escitalopram oxalate SSRI antidepressant, 10mg film-coated tablets.
- Lanzen® 30mg Gastroenterology product, lansoprazole proton pump inhibitor, 30mg extended-release capsules, indicated for duodenal and gastric ulcer, reflux esophagitis, H. pylori eradication, and related acid-related disorders.
- Factive® 320mg Infectiology product, fluoroquinolone antibiotic, 320mg dosage, for infectious disease treatment.
- Acno® 20mg Dermatology product indicated for acne treatment, 20mg dosage.
- Carteol LP® 2% Ophthalmology product, beta-blocker eye drops, 2% concentration, for ocular conditions including glaucoma.
- Physiolac 1® Pediatric product, infant formula stage 1.
- Carbozen® Pharmacy (OTC) product, dietary supplement based on charcoal for digestive comfort, relieving bloating and flatulence; presented as capsules in a box of 60.
- AIRFASTEC Respiratory product for respiratory comfort.
- Gynoflor® 0,03mg/108CFU Uro-gynecology product, vaginal tablets containing estriol and Lactobacillus acidophilus for restoring vaginal flora and treating mild vaginal infections.
- Chondrosulf® 400mg Musculoskeletal product, chondroitin sulfate, 400mg dosage, for joint and cartilage support.
Companies that use Zenith Pharma
Customer profileSegments3 records
Ideal customer profiles2 records
Zenith Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Zenith Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- International pharmaceutical firms (unspecified)coreZenith Pharma pursues strategic partnerships with the most important global pharmaceutical firms that are leaders in their respective fields. These partnerships enable the company to bring innovative products to the Moroccan market while also developing its own product portfolio.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Zenith Pharma competitors and assessment
Company assessmentBroad incumbents
- Cipla: Major Indian generic manufacturer with a strong presence in African markets including oncology, respiratory, and anti-infectives; comparable to Zenith as a generics exporter targeting emerging markets.
- Aspen Pharmacare: Largest African pharmaceutical manufacturer with broad generics, specialty, and OTC portfolios serving sub-Saharan Africa; comparable to Zenith in its African generics manufacturing ambition and broad therapeutic area coverage.
- Sanofi Maroc: Multinational pharma incumbent operating in Morocco across branded specialty and primary care; overlaps with Zenith in therapeutic categories but operates at broader portfolio scale with global R&D backing.
Direct peers
- Galenica Maroc: Moroccan pharmaceutical company with a portfolio of branded generics and specialty products across multiple therapeutic areas; comparable to Zenith in domestic manufacturing scale and hybrid commercial model.
- Laprophan: Established Moroccan pharmaceutical manufacturer with a broad prescription and OTC portfolio serving hospitals and pharmacies across Morocco; directly comparable to Zenith in domestic manufacturing and distribution focus.
- Sothema: Leading Moroccan pharmaceutical manufacturer with a diversified portfolio spanning multiple therapeutic categories including oncology, cardiology, and CNS; directly comparable in scale, market focus, and hybrid own-brand/licensed model.
- Pharma 5: Moroccan pharmaceutical group producing generics and branded products across multiple therapeutic categories; comparable to Zenith as a domestic Moroccan manufacturer with both proprietary and partnership-driven offerings.
- Cooper Pharma: One of the largest Moroccan pharmaceutical manufacturers with a broad generics portfolio across multiple therapeutic areas; directly comparable to Zenith in product breadth, domestic distribution model, and Moroccan market focus.
Regional players
- Medis (Tunisia): Tunisian pharmaceutical manufacturer with a broad generics portfolio serving Maghreb and African markets; comparable to Zenith in regional Maghreb presence, generics focus, and multi-therapeutic area strategy.
- Adcock Ingram: South African pharmaceutical manufacturer and distributor with broad prescription, OTC, and generics portfolio; comparable to Zenith in emerging-market pharma manufacturing scale and multi-channel distribution model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Zenith Pharma social profiles
Digital presenceZenith Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zenith Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Zenith Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zenith Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zenith Pharma
What does Zenith Pharma do?
Zenith Pharma develops, manufactures, and commercializes a portfolio of 207 pharmaceutical products across 12 therapeutic categories (musculoskeletal, cardiology, dermatology, gastroenterology, infectiology, oncology-hospital, ophthalmology, pediatrics, pharmacy/OTC, respiratory, central nervous system, and uro-gynecology). The company sells both proprietary in-house branded generics under the Zenith house brand and products through partnerships with leading international pharmaceutical firms, distributing these products to hospitals, clinics, and pharmacies across Morocco.
Is Zenith Pharma a public or private company?
Zenith Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Zenith Pharma founded?
Zenith Pharma was founded in 2002. It employs 101 to 250 people.
Where is Zenith Pharma based?
Zenith Pharma is headquartered in Sidi Maarouf, Morocco, in the Africa region.
How does Zenith Pharma make money?
One revenue line is on record: pharmaceutical product sales.
Who are Zenith Pharma's main competitors?
Broad incumbents on record are Cipla, Aspen Pharmacare and Sanofi Maroc. Direct peers are Galenica Maroc, Laprophan, Sothema, Pharma 5 and Cooper Pharma. Regional players are Medis (Tunisia) and Adcock Ingram.
Does Zenith Pharma have an API?
No public API is recorded for Zenith Pharma.
What industry is Zenith Pharma in?
Zenith Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIAJAA, Full-Line Pharmaceutical Wholesalers. Its NAICS code is 325412 and its SIC code is 2834.